Aigen Investment Management LP Lowers Holdings in Xylem Inc. (NYSE:XYL)

Aigen Investment Management LP reduced its stake in shares of Xylem Inc. (NYSE:XYL) by 3.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,857 shares of the industrial products company’s stock after selling 188 shares during the quarter. Aigen Investment Management LP’s holdings in Xylem were worth $791,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the stock. Swedbank AB boosted its holdings in Xylem by 22.8% during the third quarter. Swedbank AB now owns 2,991,583 shares of the industrial products company’s stock worth $403,953,000 after buying an additional 554,609 shares in the last quarter. Mirova US LLC boosted its stake in shares of Xylem by 2.0% during the 2nd quarter. Mirova US LLC now owns 1,876,618 shares of the industrial products company’s stock worth $254,526,000 after acquiring an additional 36,013 shares in the last quarter. Impax Asset Management Group plc grew its position in shares of Xylem by 1.0% during the 3rd quarter. Impax Asset Management Group plc now owns 1,677,816 shares of the industrial products company’s stock valued at $226,555,000 after acquiring an additional 15,825 shares during the period. DekaBank Deutsche Girozentrale increased its stake in shares of Xylem by 2.2% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 1,665,090 shares of the industrial products company’s stock valued at $227,364,000 after purchasing an additional 36,601 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in Xylem by 8.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,474,033 shares of the industrial products company’s stock worth $199,930,000 after purchasing an additional 113,571 shares during the period. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Stock Performance

NYSE:XYL opened at $124.79 on Wednesday. The company’s 50-day moving average is $131.09 and its two-hundred day moving average is $134.93. Xylem Inc. has a 1-year low of $98.21 and a 1-year high of $146.08. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.96 and a quick ratio of 1.42. The firm has a market capitalization of $30.32 billion, a price-to-earnings ratio of 36.49, a PEG ratio of 2.29 and a beta of 1.05.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Thursday, October 31st. The industrial products company reported $1.11 earnings per share for the quarter, hitting the consensus estimate of $1.11. Xylem had a return on equity of 9.61% and a net margin of 9.85%. The company had revenue of $2.10 billion during the quarter, compared to analyst estimates of $2.17 billion. During the same period in the prior year, the business posted $0.99 earnings per share. The firm’s revenue for the quarter was up .2% compared to the same quarter last year. Analysts forecast that Xylem Inc. will post 4.23 EPS for the current year.

Xylem Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, September 26th. Shareholders of record on Thursday, August 29th were paid a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a yield of 1.15%. The ex-dividend date was Thursday, August 29th. Xylem’s dividend payout ratio (DPR) is presently 42.11%.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on XYL shares. TD Cowen cut their price target on shares of Xylem from $138.00 to $125.00 and set a “hold” rating for the company in a report on Wednesday, November 6th. Stifel Nicolaus upped their price target on shares of Xylem from $170.00 to $172.00 and gave the stock a “buy” rating in a research report on Wednesday, July 31st. Royal Bank of Canada lowered their price objective on Xylem from $163.00 to $162.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. UBS Group initiated coverage on Xylem in a report on Tuesday, August 13th. They set a “buy” rating and a $165.00 target price for the company. Finally, Robert W. Baird lowered their price target on Xylem from $175.00 to $154.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Four investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat, Xylem has an average rating of “Moderate Buy” and a consensus target price of $147.17.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.